Concepedia

George H. Addona

GH

Statistics

Publications

23

Citations

1.6K

H-Index

17

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Massachusetts General Hospital

Harvard University

United States Military Academy

University of Virginia

George H. Addona is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicinePharmacologyBiochemistryDrug DiscoveryImmunologyPhysiologyImmunotherapyTumor BiologyNatural SciencesMolecular Biology

Publications per year

1995–2022

23

Publications

23

An orally available non-nucleotide STING agonist with antitumor activity

Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 609 citations

Antitumor Activity, Immunology, Immunoediting +19

Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer

Wonsuk Chang, Michael D. Altman, Charles A. Lesburg et al. · Journal of Medicinal Chemistry · 2022 · 122 citations · Full text

Immunology, Molecular Biology, Interferon Genes +17

The cholesterol dependence of activation and fast desensitization of the nicotinic acetylcholine receptor

Saffron E. Rankin, George H. Addona, Marek Kloczewiak et al. · Biophysical Journal · 1997 · 113 citations · Full text

Fast Desensitization, Oxysterol, Biochemistry +7

A multiplexed microfluidic system for evaluation of dynamics of immune–tumor interactions

Nathan W. Moore, Daniel Doty, Mark Zielstorff et al. · Lab on a Chip · 2018 · 99 citations

Flow Control, Engineering, Multiplexed Microfluidic System +21

PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain

Mali Liu, Guoxin Wu, Jennifer Baysarowich et al. · Journal of Lipid Research · 2010 · 97 citations · Full text

Cell Death, Neurochemical Biomarkers, Neuroinflammation +18

1–5 of 23